Creso Pharma |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 14 November 2026 at 7:13pm | ||||
|
Market Cap (14-Nov) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
Appendix 4G and Corporate Governance Statement
CPH released this announcement to the ASX on 31 March 2023, 16:49. The announcement is not marked as price sensitive, and is 32 page(s) in length and 465.5kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.076% short sold according to ASIC data. It was ranked the 492nd most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| Appendix 4G and Corporate Governance Statement | 31 March 2023, 16:49 |
| Annual Report to Shareholders | 31 March 2023, 16:47 |
| HHI: Scheme consideration update | 31 March 2023, 13:59 |
| HHI: Dispatch of scheme booklet-scheme of arrangement CPH | 30 March 2023, 16:48 |
If you were already registered, log in here.